Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Blood Dyscrasia Patients”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Looking for participantsNCT05776979
What this trial is testing

Post-Transplant Maintenance Therapy With Isatuximab Plus Lenalidomide for High-Risk Multiple Myeloma Patients

Who this might be right for
Multiple Myeloma
M.D. Anderson Cancer Center 61
Very early researchStudy completedNCT02802696
What this trial is testing

Transfusion-Associated Circulatory Overload Best Eliminated With Lasix

Who this might be right for
Transfusion-associated Circulatory Overload
Sunnybrook Health Sciences Centre 80
Early research (Phase 1)Ended earlyNCT02255162
What this trial is testing

Lenalidomide in Combination With Microtransplantation as Post-remission Therapy in AML

Who this might be right for
Acute Myeloid Leukemia (AML)Acute Myelocytic LeukemiaAcute Myelogenous Leukemia+2 more
Massachusetts General Hospital 8
Very early researchLooking for participantsNCT04657861
What this trial is testing

APRIL CAR-T Cell Therapy for Patients With BCMA/TACI Positive Relapsed and/or Refractory Multiple Myeloma

Who this might be right for
Multiple Myeloma in RelapseMultiple Myeloma, Refractory
Zhejiang University 36
Not applicableEnded earlyNCT04947618
What this trial is testing

Efficacy of Patient Management for Lymphoma Diagnosed at Nimes University Hospital From 1999 to 2018. DVR-Lym-Nim

Who this might be right for
Lymphoma, Malignant
Centre Hospitalier Universitaire de Nīmes 136
Not applicableNot Yet RecruitingNCT06472479
What this trial is testing

LCAR-M61S and LCAR-M61D in Treatment of Relapsed/Refractory Multiple Myeloma

Who this might be right for
Relapsed/Refractory Multiple Myeloma
The First Affiliated Hospital with Nanjing Medical University 66
Testing effectiveness (Phase 2)Ended earlyNCT00363779
What this trial is testing

Effect of Cyclosporine Therapy on Gene Expression in Patients With Large Granular Lymphocyte Leukemia

Who this might be right for
Large Granular Lymphocytic LeukemiaLGL Leukemia
National Cancer Institute (NCI) 5
Testing effectiveness (Phase 2)Looking for participantsNCT05855083
What this trial is testing

Efficacy and Safety Study of Narsoplimab in Pediatric Patients With High-Risk Hematopoietic Stem Cell Transplant TMA

Who this might be right for
Thrombotic MicroangiopathiesHematopoietic Stem Cell Transplantation
Omeros Corporation 18
Testing effectiveness (Phase 2)Study completedNCT04312841
What this trial is testing

Letermovir for the Prevention of Cytomegalovirus Reactivation in Patients With Hematological Malignancies Treated With Alemtuzumab

Who this might be right for
B-Cell Prolymphocytic LeukemiaChronic Lymphocytic LeukemiaPeripheral T-Cell Lymphoma+3 more
Ohio State University Comprehensive Cancer Center 6
Testing effectiveness (Phase 2)Study completedNCT00041990
What this trial is testing

Phase II Trial of Decitabine in Patients With Chronic Myelogenous Leukemia Accelerated Phase Who Are Refractory to Imatinib Mesylate (Gleevec)

Who this might be right for
Chronic Myelogenous Leukemia
Astex Pharmaceuticals, Inc. 40
Testing effectiveness (Phase 2)Study completedNCT00195624
What this trial is testing

Alemtuzumab to Treat Severe Aplastic Anemia

Who this might be right for
Severe Aplastic Anemia, RefractorySevere Aplastic Anemia, Relapse
National Heart, Lung, and Blood Institute (NHLBI) 47
Testing effectiveness (Phase 2)Study completedNCT02639559
What this trial is testing

Safety and Efficacy of BL-8040 for the Mobilization of Donor Hematopoietic Stem Cells and Allogeneic Transplantation in Patients With Advanced Hematological Malignancies

Who this might be right for
Acute Myelogenous LeukemiaAcute Lymphoblastic LeukemiaChronic Myelogenous Leukemia+8 more
Washington University School of Medicine 50
Testing effectiveness (Phase 2)Study completedNCT02332980
What this trial is testing

Pembrolizumab Alone or With Idelalisib or Ibrutinib in Treating Patients With Relapsed or Refractory Chronic Lymphocytic Leukemia or Other Low-Grade B-Cell Non-Hodgkin Lymphomas

Who this might be right for
Recurrent B-Cell Non-Hodgkin LymphomaRecurrent Chronic Lymphocytic LeukemiaRecurrent Extranodal Marginal Zone Lymphoma of Mucosa-Associated Lymphoid Tissue+20 more
Mayo Clinic 65
Testing effectiveness (Phase 2)Study completedNCT03390296
What this trial is testing

OX40, Venetoclax, Avelumab, Glasdegib, Gemtuzumab Ozogamicin, and Azacitidine in Relapsed or Refractory Acute Myeloid Leukemia

Who this might be right for
Recurrent Acute Myeloid LeukemiaRefractory Acute Myeloid Leukemia
M.D. Anderson Cancer Center 50
Testing effectiveness (Phase 2)Study completedNCT03734588
What this trial is testing

Dose-finding Study of SPK-8016 Gene Therapy in Patients With Hemophilia A to Support Evaluation in Individuals With FVIII Inhibitors

Who this might be right for
Adeno-Associated Virus (AAV)Blood Coagulation DisorderBlood Coagulation Disorders, Inherited+14 more
Spark Therapeutics, Inc. 4
Not applicableEnrolling By InvitationNCT05212103
What this trial is testing

PET Imaging of Cancer Patients Using 68Ga-DOTA-Siglec-9

Who this might be right for
Acute Myeloid LeukemiaMelanomaNon Small Cell Lung Cancer
Turku University Hospital 30
Testing effectiveness (Phase 2)Active Not RecruitingNCT04497961
What this trial is testing

Health-Related Quality of Life in People With Multiple Myeloma Receiving Daratumumab or Lenalidomide

Who this might be right for
Multiple Myeloma
Memorial Sloan Kettering Cancer Center 95
Not applicableStudy completedNCT01811342
What this trial is testing

Continuous Hemoglobin Evaluation

Who this might be right for
Anemia
University of California, Davis 70
Early research (Phase 1)WithdrawnNCT07428486
What this trial is testing

FLAG Chemotherapy In Combination With Lisaftoclax And Pelcitoclax In Patients With Relapsed/Refractory T-Cell Acute Lymphoblastic Leukemia

Who this might be right for
Phase IFLAG ChemotherapyLisaftoclax+3 more
M.D. Anderson Cancer Center
Large-scale testing (Phase 3)Study completedNCT02246868
What this trial is testing

An Open Study to Investigate the Safety and Efficacy of Optivate® in Severe Haemophilia A Patients.

Who this might be right for
Haemophilia A
Bio Products Laboratory
Next Page